Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Purple Biotech (PPBT) Depreciation Expense (2017 - 2025)

Purple Biotech has reported Depreciation Expense over the past 6 years, most recently at $50000.0 for Q4 2022.

  • Quarterly Depreciation Expense fell 18.03% to $50000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $201000.0 through Dec 2022, down 12.99% year-over-year, with the annual reading at $203000.0 for FY2025, 9.14% up from the prior year.
  • Depreciation Expense was $50000.0 for Q4 2022 at Purple Biotech, up from $47000.0 in the prior quarter.
  • Over five years, Depreciation Expense peaked at $143000.0 in Q4 2020 and troughed at $4000.0 in Q4 2018.
  • The 5-year median for Depreciation Expense is $53000.0 (2022), against an average of $60272.7.
  • Year-over-year, Depreciation Expense skyrocketed 2000.0% in 2019 and then crashed 57.34% in 2021.
  • A 5-year view of Depreciation Expense shows it stood at $4000.0 in 2018, then skyrocketed by 2000.0% to $84000.0 in 2019, then surged by 70.24% to $143000.0 in 2020, then crashed by 57.34% to $61000.0 in 2021, then decreased by 18.03% to $50000.0 in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Depreciation Expense are $50000.0 (Q4 2022), $47000.0 (Q3 2022), and $53000.0 (Q2 2022).